ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: M.D. Anderson Selects Raphael Pollock To Lead Surgery Div.; S.F. VA Picks Norton

September 12, 1997

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

Roche Markets CMV Test in Europe

April 29, 2011

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013